Related Experiment Video
Updated: Jun 23, 2026

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Prognostication and Interventional Guidance Using Acceleration-Ejection Time Ratio in Undifferentiated Paradoxical
Adrian Chong1, Jonathan Sen2, Reza Reyaldeen3
1Princess Alexandra Hospital, Brisbane, Australia; Faculty of Medicine, University of Queensland, Brisbane, Australia.
The acceleration (AT) to ejection (ET) time ratio (AT:ET) ≥0.35 predicts worse outcomes in paradoxical low-flow low-gradient aortic stenosis (PLFAS). Aortic valve replacement (AVR) significantly benefits patients with AT:ET ≥0.35, improving survival.
Area of Science:
- Cardiology
- Echocardiography
- Cardiac Surgery
Background:
- Paradoxical low-flow low-gradient aortic stenosis (PLFAS) presents diagnostic challenges due to heterogeneous patient populations and uncertain stenosis severity.
- Outcomes following aortic valve replacement (AVR) in PLFAS patients are variable, complicating clinical decision-making.
Purpose of the Study:
- To evaluate the acceleration (AT) to ejection (ET) time ratio (AT:ET) as a prognostic marker in undifferentiated PLFAS.
- To determine the utility of AT:ET for predicting the benefit of AVR in PLFAS patients.
Main Methods:
- Echocardiographic data from 171 PLFAS patients were analyzed, defining PLFAS by specific aortic valve area, gradient, stroke volume, and ejection fraction criteria.
- Patients were stratified based on an AT:ET ratio cutoff of 0.35.
- The primary outcome was a composite of 5-year cardiac mortality or AVR, with secondary outcomes including all-cause mortality and individual endpoint components. The impact of AVR was assessed within AT:ET subgroups.
Main Results:
- An AT:ET ratio ≥0.35 independently predicted the primary outcome (cardiac mortality or AVR) and was associated with increased cardiac death and need for AVR.
- The AT:ET ratio demonstrated incremental prognostic value over standard stenosis severity indices.
- Aortic valve replacement in patients with AT:ET ≥0.35 was linked to substantial reductions in 5-year cardiac and all-cause mortality, whereas AVR offered no survival benefit in the AT:ET <0.35 group.
Conclusions:
- An AT:ET ratio ≥0.35 identifies PLFAS patients with poorer prognosis and a higher likelihood of requiring AVR.
- The AT:ET ratio shows potential as a valuable tool for optimizing patient selection for prognostic AVR in PLFAS.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Aortic Regurgitation IV: Nursing Management